Open access · OA
via Europe PMC
Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
Pang X, Geng N, Lu C, Zhao Q, Shi J, Xiong Y, Li W, Li J.
Hepatology communications · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
X, P., N, G., C, L., Q, Z., J, S., Y, X., W, L., & J., L. (2026). Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD). <em>Hepatology communications</em>. https://europepmc.org/article/PMC/PMC13668295
Vancouver
X P, N G, C L, Q Z, J S, Y X, et al. Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD). Hepatology communications. 2026.
BibTeX
@article{pang2026Hepato,
title = {Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)},
author = {Pang X and Geng N and Lu C and Zhao Q and Shi J and Xiong Y and Li W and Li J.},
journal = {Hepatology communications},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Gastroenterology and Hepatology 2026
Citation only
Association of Metabolic Dysfunction–Associated Steatotic Liver Disease Onset Age With Risk of Incident Type 2 Diabetes
Gastroenterology 2006
Open access · OA
Intestinal Failure–Associated Liver Disease: What Do We Know Today?
Assiut University 2026
Open access · US-GOV
Sarcopenia Among Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
Nature Aging 2024
Preprint · OA
Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress
Aging cell 2026
Open access · OA
Inhibiting Glutaminase Reverses Senescence‐Associated Mitochondrial Dysfunction and Skeletal Muscle Decline
Cell Communication and Signaling 2025
Open access · CC-BY